glp-1 medical weight loss Unlocking Sustainable with Weight Loss Medications and Peptides at Illume Med Spa First 90 Days on GLP-1

People who had been tracking their tirzepatide weight loss progress found themselves at a crossroads

The prevalence of comorbidities was as follows: 51.1% of patients with hypertension, 50% with diabetes mellitus, 5.2% with psychoactive substance use, and 0.5% experiencing problems related to housing and economic circumstances

The most important approach is gradual dose titration : starting with the lowest available dose and increasing slowly according to the manufacturer's recommended schedule allows the gastrointestinal system time to adapt

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic

I have been living with mast cell activation syndrome (MCAS) long enough to know how exhausting it is